Clinical Trials Directory

Trials / Completed

CompletedNCT01215734

Standard vs High-Dose Trivalent Inactivated Flu Vaccine in Adult Hematopoetic Stem Cell Transplant (HSCT) Recipients

Randomized Double-Blind, Comparison of Standard Dose Trivalent Inactivated Influenza Vaccine Versus High-Dose Trivalent Inactivated Influenza Vaccine in Adult Stem Cell Hematopoetic Transplant Recipients

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
44 (actual)
Sponsor
Vanderbilt-Ingram Cancer Center · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Hypothesis 1: The safety profile in adult allogeneic stem cell hematopoietic transplant (SCT) recipients after high dose (HD) trivalent inactivated influenza vaccine (TIV) will not be significantly different from adult stem cell transplant recipients receiving standard dose (SD) TIV. * Specific Aim 1: To compare safety profile of high dose trivalent inactivated influenza vaccine to standard dose trivalent inactivated influenza vaccine in adult hematopoietic stem cell transplant recipients. Hypothesis 2: Adult stem cell transplant recipients who received the higher dose trivalent influenza vaccine will have a greater frequency of (at least a 4-fold) rise in antibody titers to influenza antigens compared to those who receive standard dose trivalent influenza vaccine. * Specific Aim 2: To compare humoral immune responses of adult hematopoietic stem cell transplant recipients influenza virus antigens included in trivalent influenza vaccine after high dose or standard dose trivalent influenza vaccine.

Conditions

Interventions

TypeNameDescription
BIOLOGICALHigh-Dose Trivalent Inactivated Influenza Vaccine (HD-TIV)0.5 ml of HD-TIV on visit 1
BIOLOGICALStandard Dose Trivalent Inactivated Flu VaccineTwenty adult hematopoetic stem cell transplant recipients will receive 0.5 ml standard dose trivalent influenza vaccine on visit 1.

Timeline

Start date
2010-10-01
Primary completion
2012-04-01
Completion
2012-09-01
First posted
2010-10-06
Last updated
2013-03-08
Results posted
2013-03-08

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01215734. Inclusion in this directory is not an endorsement.